The WHO established November 17 as the Day of Action for the Elimination of Cervical Cancer, marking the anniversary of the launch of the global Strategy to accelerate the elimination of cervical cancer by 2030.
This disease remains the second leading cause of oncological death in Venezuelan women, with alarming incidence data, especially because diagnoses are recorded at increasingly younger ages (from 20 years old).
The Santa Paula Medical Group (GMSP) highlights prevention and underlines that this disease is curable if detected in time, with its main causative agent being the Human Papillomavirus (HPV), responsible for the vast majority of lesions.
You can also read: Spanish writer Irene Vallejo vindicates curiosity as an antidote to fear
Risk Factors Dr. Francisco Pestana, a gynecologist at GMSP, emphasizes that prevention is based on information and periodic check-ups: "The patient must know the risks, such as early sexual relations without protection or having multiple partners. Second, she must undergo a cytology test every year, which is very important because we have a high incidence of HPV in the country, almost 92 to 95% of women have this positive typing." This virus presents different strains, some of which are significantly more virulent in oncological terms. This difference underscores the importance of rapid and accurate identification of its type (genotyping) to ensure effective and timely therapeutic management. The specialist confirms that the fundamental measure is the annual preventive cytological control, complemented by colposcopy to verify the health of the cervix and, in cases of injury, the histological study (biopsy). The symptom that should immediately alert you is postcoital bleeding or spontaneous bleeding. However, Dr. Pestana insists that "it is unlikely that a patient who has regular check-ups in her gynecological consultation will have cancer." Therefore, "it is important to have a Pap smear regularly." For awareness, the doctor highlights the importance of continuous promotion and education.Vaccine
Vaccination against HPV (available in tetravalent and nonavalent versions) is another crucial tool, approved for use from 9 years of age and highly effective before the start of sexual relations. The GMSP remains a pioneer by conducting detection campaigns and using high-tech equipment to ensure accurate diagnoses, such as HPV genotyping, which allows for the establishment of effective treatment and surveillance protocols. Comprehensive gynecology and detection services The Santa Paula Medical Group offers a comprehensive and specialized service for the prevention and management of CCU, which includes: · Gynecology and Obstetrics consultations. · Annual Cytology and Colposcopy. · HPV typing tests and risk assessment (9 types of the virus). · Biopsies and specialized follow-up of lesions. · Processing tests on high-end technology equipment to detect even the smallest injuries. · HPV prevention and vaccination programs. With the solid backing of Keralty, the Santa Paula Medical Group reaffirms its dedication to healthcare excellence. Our focus is on providing users and professionals with innovative solutions that guarantee expedited access to the highest quality of services, which is why it is "the clinic that everyone has in mind". To be attended at GMSP, request appointments and obtain more information, you must call 0500 CUIDATE (2843283) or (0212) 9176200, or you can write via WhatsApp to 0414/0424/0412/0422 CLINICA (2546422), also consult the page: www.grupomedicosp.com. In addition, you can follow them as @grupomedicosp on social media Instagram, TikTok, Facebook, X, Threads and on their YouTube channel.






